ReGen Therapeutics Limited services

The sedative zolpidem (marketed by Sanofi-Aventis under the trade names Stilnox™ and Ambien™) has been used for the last twenty years as a hypnotic/sedative by millions of people.  It is now off patent and an alternative use has now been discovered which is owned by ReGen.

During ReGen’s discussions with potential licensing partners in 2004, it became apparent that a product based on the Colostrinin™ complex, as a whole, was more commercially attractive as a nutraceutical, rather than as a pharmaceutical.  It was decided, therefore, to develop the original formulation of Colostrinin™ as a nutraceutical.